RXST Logo

RxSight, Inc. (RXST) 

NASDAQ
Market Cap
$1.39B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
121 of 959
Rank in Industry
10 of 120

Largest Insider Buys in Sector

RXST Stock Price History Chart

RXST Stock Performance

About RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction …

Insider Activity of RxSight, Inc.

Over the last 12 months, insiders at RxSight, Inc. have bought $1.73M and sold $26.76M worth of RxSight, Inc. stock.

On average, over the past 5 years, insiders at RxSight, Inc. have bought $7.78M and sold $31.49M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Corley Jesse Anderson (director) — $1.01M. Tammenoms Bakker Juliet (director) — $712,129.

The last purchase of 11,365 shares for transaction amount of $510,491 was made by Corley Jesse Anderson (director) on 2024‑11‑13.

List of Insider Buy and Sell Transactions, RxSight, Inc.

2024-11-29SaleSee remarks
3,105
0.0076%
$46.08$143,078-17.17%
2024-11-26SaleSee remarks
3,100
0.0077%
$45.88$142,228-14.41%
2024-11-26Saledirector
3,782
0.0093%
$45.88$173,518-14.41%
2024-11-22SaleSee remarks
3,100
0.0078%
$45.00$139,500-8.59%
2024-11-18SaleSee remarks
3,100
0.0078%
$45.00$139,502-0.76%
2024-11-15SaleSee remarks
4,875
0.0126%
$46.00$224,250-4.22%
2024-11-13Purchasedirector
11,365
0.0284%
$44.92$510,491-3.35%
2024-11-12SaleSee remarks
1,330
0.0033%
$46.13$61,356-5.06%
2024-11-12Purchasedirector
11,111
0.0275%
$45.37$504,079-5.06%
2024-11-07SaleSee remarks
3,100
0.0084%
$55.00$170,495-13.26%
2024-11-04SaleSee remarks
3,100
0.0077%
$51.05$158,247-12.72%
2024-10-30SaleSee remarks
3,105
0.0079%
$51.91$161,171-12.46%
2024-10-28SaleSee remarks
3,100
0.0079%
$50.64$156,993+3.00%
2024-10-25SaleSee remarks
3,100
0.0077%
$49.79$154,3600.00%
2024-10-22SaleSee remarks
3,100
0.0077%
$49.68$154,0010.00%
2024-10-18SaleSee remarks
3,105
0.0078%
$50.09$155,533-10.74%
2024-10-16SaleSee remarks
3,100
0.008%
$49.78$154,318-10.67%
2024-10-14SaleSee remarks
3,100
0.008%
$50.09$155,268-9.17%
2024-10-11SaleSee remarks
3,100
0.008%
$50.19$155,594-8.69%
2024-10-10SaleSee remarks
3,105
0.0078%
$48.82$151,596-7.92%

Insider Historical Profitability

<0.0001%
Kurtz Ronald M MDPresident & CEO
764610
1.8971%
$34.4724<0.0001%
Corley Jesse Andersondirector
474141
1.1764%
$34.4742<0.0001%
Weinberg EricChief Commercial Officer
299978
0.7443%
$34.4756<0.0001%
Goldshleger IlyaSee remarks
42246
0.1048%
$34.47136<0.0001%
Tammenoms Bakker Julietdirector
34840
0.0864%
$34.47510+44.34%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
RA Capital Management, L.P.$177.58M8.843.44M+1.13%+$1.99M0.18
BlackRock$108.81M5.422.11M+1.59%+$1.71M<0.01
Artisan Partners$97.78M4.871.9M-20.87%-$25.79M0.14
Lord Abbett$91.42M4.551.77M-10.35%-$10.55M0.32
The Vanguard Group$78.63M3.911.52M+2.73%+$2.09M<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.